Anixa Biosciences presents at Cantor Fitzgerald Global Healthcare Conference on breast cancer vaccine progress
ANIX•Conference presentation scheduled for Sept. 11
Anixa Biosciences will attend the 2026 Cantor Fitzgerald Global Healthcare Conference in New York on Sept. 9-11, 2026.
A management presentation is scheduled for Sept. 11, 2026 at 8:00 a.m. ET.
Update to cover breast cancer vaccine and ovarian cancer CAR-T work
The update will cover Phase 1 breast cancer vaccine results, with immune responses in 74% of participants.
Discussion will also include lira-cel ovarian cancer CAR-T dosing in the fifth cohort, with no dose-limiting toxicities reported.
Related News
Lion Group plans to keep Hyperliquid HYPE tokens as part of treasury strategy, holds 195,000 HYPE valued at USD 15.8 million
LGHL•
BRIEF-Cyabra Announces Contracts With Two European National Security Agencies Worth Over $500,000 Annually
CYAB•
